Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-28T06:42:49.976Z Has data issue: false hasContentIssue false
  • English
  • Français

Hand Hygiene Noncompliance and the Cost of Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Infection

Published online by Cambridge University Press:  02 January 2015

Keith L. Cummings ,
Deverick J. Anderson  and
Keith S. Kaye
Keith L. Cummings*
Affiliation:
Department of Medicine, Duke University Medical Center, Durham, North Carolina
Deverick J. Anderson
Affiliation:
Department of Medicine, Duke University Medical Center, Durham, North Carolina
Keith S. Kaye
Affiliation:
Department of Medicine, Wayne State University, Detroit Medical Center, Detroit, Michigan
*
3990 John R, Detroit, MI 27710 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background.

Hand hygiene noncompliance is a major cause of nosocomial infection. Nosocomial infection cost data exist, but the effect of hand hygiene noncompliance is unknown.

Objective.

To estimate methicillin-resistant Staphylococcus aureus (MRSA)-related cost of an incident of hand hygiene noncompliance by a healthcare worker during patient care.

Design.

Two models were created to simulate sequential patient contacts by a hand hygiene-noncompliant healthcare worker. Model 1 involved encounters with patients of unknown MRSA status. Model 2 involved an encounter with an MRSA-colonized patient followed by an encounter with a patient of unknown MRSA status. The probability of new MRSA infection for the second patient was calculated using published data. A simulation of 1 million noncompliant events was performed. Total costs of resulting infections were aggregated and amortized over all events.

Setting.

Duke University Medical Center, a 750-bed tertiary medical center in Durham, North Carolina.

Results.

Model 1 was associated with 42 MRSA infections (infection rate, 0.0042%). Mean infection cost was $47,092 (95% confidence interval [CI], $26,040–$68,146); mean cost per noncompliant event was $1.98 (95% CI, $0.91–$3.04). Model 2 was associated with 980 MRSA infections (0.098%). Mean infection cost was $53,598 (95% CI, $50,098–$57,097); mean cost per noncompliant event was $52.53 (95% CI, $47.73–$57.32). A 200-bed hospital incurs $1,779,283 in annual MRSA infection-related expenses attributable to hand hygiene noncompliance. A 1.0% increase in hand hygiene compliance resulted in annual savings of $39,650 to a 200-bed hospital.

Conclusions.

Hand hygiene noncompliance is associated with significant attributable hospital costs. Minimal improvements in compliance lead to substantial savings.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 31 , Issue 4 , April 2010 , pp. 357 - 364
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Klevens, RM, Edwards, JR, Horan, T, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007;122(2:160–166.Google Scholar
2. Kopp, BJ, Nix, DE, Armstrong, EP. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections. Ann Phar-macother 2004;38(9:1377–1382.Google Scholar
3. Smith, RL II, Sawyer, RG, Pruett, TL. Hospital-acquired infections in the surgical intensive care: epidemiology and prevention. Zentralbl Chir 2003;128(12:1047–1061.Google ScholarPubMed
4. Abramson, MA, Sexton, DJ. Nosocomial methicillin-resistant and meth-icillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999;20(6:408–411.Google Scholar
5. Aragon, D, Sole, ML, Brown, S. Outcomes of an infection prevention project focusing on hand hygiene and isolation practices. AACN Clin Issues 2005;16(2:121–132.Google Scholar
6. Pittet, D, Hugonnet, S, Harbarth, S, et al; Infection Control Programme. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 2000;356(9238:1307–1312.Google Scholar
7. Larson, EL, et al. An organizational climate intervention associated with increased handwashing and decreased nosocomial infections. Behav Med 2000;26(1):14–22.Google Scholar
8. Boyce, JM, Pittet, D. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Am J Infect Control 2002;30(8):S1–S46.Google Scholar
9. The Joint Commission. 2008 Patient safety goals. The Joint Commission Web site. http://www.jcrinc.com/fpdf/pubs/pdfs/JCReqs/JCP-07-07-S1.pdf. Published 2007. Accessed May 28, 2008.Google Scholar
10. World Health Organization. WHO guidelines on hand hygiene in health care (advanced draft): a summary. World Health Organization Web site. http://www.who.int/patientsafety/events/05/HH_en.pdf. Published 2005. Accessed May 28, 2008.Google Scholar
11. Wullenweber, M, Martiny, H, Lenz, W, et al. Nosocomial infective agents in a surgical intensive care unit. III. Spreading of Staphylococcus aureus with regard to phage typing analysis [in German]. Zentralbl Bakteriol Mikrobiol Hyg [B] 1981;174(6:498–508.Google Scholar
12. Centers for Disease Control and Prevention. Guidelines for hand hygiene in healthcare settings—2002. Centers for Disease Control and Prevention Web site, http://cdc.gov/handhygiene/. Accessed January 30, 2009.Google Scholar
13. Pittet, D. Improving adherence to hand hygiene practice: a multidisciplinary approach. Emerg Infect Dis 2001;7(2:234–240.Google Scholar
14. Mauldin, PD, Saigado, CD, Durkalski, VL, et al. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: relationships with antibiotic use and cost drivers. Ann Phar-macother 2008;42(3:317–326.Google Scholar
15. Anderson, DJ, Kirkland, KB, Kaye, KS, et al. Underresourced hospital infection control and prevention programs: penny wise, pound foolish? Infect Control Hosp Epidemiol 2007;28(7:767–773.Google Scholar
16. Engemann, JJ, Carmeli, Y, Cosgrove, SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36(5:592–598.Google Scholar
17. Jarvis, WR, Schlosser, J, Chinn, RY, et al. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2006. Am J Infect Control 2007;35(10:631–637.Google Scholar
18. Dedrick, RE, Sinkowitz-Cochran, RL, Cunningham, C, et al. Hand hygiene practices after brief encounters with patients: an important opportunity for prevention. Infect Control Hosp Epidemiol 2007;28(3:341–345.Google Scholar
19. Cosgrove, SE, Qi, Y, Kaye, KS, et al. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005;26(2:166–174.Google Scholar
20. Chaix, C, Durand-Zaleski, I, Alberti, C, et al. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999;282(18:1745–1751.CrossRefGoogle Scholar
21. Lodise, TP, McKinnon, PS. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis 2005;52(2:113–122.Google Scholar
22. Shorr, AF, Tabak, YP, Gupta, V, Johannes, RS, Liu, LZ, Kollef, MH. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care 2006;10(3):article R97. http://ccforum.eom/content/10/3/R97. Published June 29, 2006. Accessed January 30, 2009.Google Scholar
23. Fitzpatrick, F, Murphy, OM, Brady, A, et al. A purpose built MRSA cohort unit. J Hosp Infect 2000;46(4:271–279.Google Scholar
24. Huang, SS, Datta, R, Platt, R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med 2006;166(18:1945–1951.CrossRefGoogle ScholarPubMed
25. Kuehnert, MJ, Doyle, TJ, Hill, HA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 2006;193(2): 172–179.Google Scholar
26. Larson, E. Skin hygiene and infection prevention: more of the same or different approaches? Clin Infect Dis 1999;29(5:1287–1294.Google Scholar
27. Albrich, WC, Harbarth, S. Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis 2008;8(5:289–301.Google Scholar
28. Huang, SS, Platt, R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003;36(3): 281–285.Google Scholar
29. Hidron, AI, Edwards, JR, Patel, J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29(11:996–1011.Google Scholar